Raphaël Jumeau

ORCID: 0000-0001-6312-3663
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Esophageal and GI Pathology
  • Lung Cancer Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Colorectal and Anal Carcinomas
  • Atrial Fibrillation Management and Outcomes
  • Brain Metastases and Treatment
  • Trauma Management and Diagnosis
  • Urologic and reproductive health conditions
  • Respiratory viral infections research
  • Cardiac pacing and defibrillation studies
  • Urinary and Genital Oncology Studies
  • Atomic and Subatomic Physics Research
  • Cardiac electrophysiology and arrhythmias
  • Sarcoidosis and Beryllium Toxicity Research
  • Genital Health and Disease
  • Cardiac Structural Anomalies and Repair
  • Lung Cancer Treatments and Mutations
  • Amoebic Infections and Treatments
  • Head and Neck Cancer Studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cancer Immunotherapy and Biomarkers
  • Cardiac tumors and thrombi
  • Radiopharmaceutical Chemistry and Applications

University of Lausanne
2015-2023

University Hospital of Lausanne
2016-2018

In patients with primary or secondary lung tumour treated immune checkpoint inhibitors, immune-related pneumonitis is a rare adverse event but may evolve to respiratory failure. Prompt management required and usually consists of treatment interruption immunosuppressive drug administration. The aim this study was evaluate relationships between pre-existing parenchymal status, especially location history chest radiotherapy. Computed tomography (CT) scans were retrospectively reviewed. Pattern,...

10.1183/23120541.00165-2019 article EN cc-by-nc ERJ Open Research 2020-01-01

To report oncological outcomes and toxicity rates, of definitive platin-based chemoradiadiationtherapy (CRT) in the management proximal esophageal cancer. We retrospectively reviewed medical records patients with cT1-4 cN0-3 cM0 cervical cancer (CEC) (defined as tumors located below inferior border cricoid cartilage, down to 22 cm from incisors) treated between 2004 2013 platin–based CRT four Swiss institutions. Acute chronic toxicities were scored using National Cancer Institute's Common...

10.1186/s13014-017-0834-8 article EN cc-by Radiation Oncology 2017-06-14

Background Cardiac sarcoidosis is associated with heart failure, conduction abnormalities, and life-threatening arrhythmias including ventricular tachycardia (VT). Radiotherapy has been suggested as a treatment for extra-cardiac in patients refractory to immunomodulatory treatment. Methods The effectiveness safety of low-dose whole-heart radiotherapy therapy cardiac were evaluated pre- post-intervention case report comparing the 54 months before after Immunomodulatory irradiation consisted 2...

10.3389/fcvm.2023.1213165 article EN cc-by Frontiers in Cardiovascular Medicine 2023-07-21

Although cardiac metastases (CM) are more common than primary malignant tumors, they remain a rare localization of metastatic cancer. Until recently, CM were surgically treated as palliative approach because lack ablative solutions even for oligometastatic patients. Technological advances in radiation therapy (RT) thoracic oncology have led to high precision delivery that enlarged the indications stereotactic body radiotherapy (SBRT). To date, there limited reports SBRT CM. Herein, we report...

10.1016/j.ctro.2019.10.005 article EN cc-by-nc-nd Clinical and Translational Radiation Oncology 2019-11-03

_____________________________________________________________________________________________________to total mesorectum and pelvic lymphatic drainage with simultaneous integrated boost (SIB) to the tumor bed adjacent mesorectum.Fluoropirimidine-based CT was administered.The acute toxicity evaluated according CTCAE 4.0 scale.Results: Pts characteristics: median age 63.5yy (range 29-84), distance-IAS 50 mm 0-100), size 25-120), MRF involvement 24 pts, Stage IIA 7 pts -III 62 pts.All of...

10.1016/s0167-8140(16)32554-3 article EN cc-by-nc-nd Radiotherapy and Oncology 2016-04-01
Coming Soon ...